Relationship between white blood cell count at admission and short term outcome in patients with acute cerebral infarction Abstract Purpose: We studied the association between admission white blood cell (WBC) count and short term outcome in patients with acute cerebral infarction.
Stroke is the leading cause of death and long-term disability worldwide [1] . In China, stroke is the third leading cause of death for males and the second leading cause for females, and the morbidity and mortality of stroke are higher compared with other countries [2] . Atherosclerosis is one of the major mechanisms of stroke [3] . Recent evidence suggests that atherosclerosis is an in ammatory condition [4] . White blood cells (WBC) play an important role in the initiation and propagation of the atherosclerotic process and WBC count has been shown to be associated with an increased risk of stroke [5] . A study showed that WBC count was predictive of rst ischemic stroke, a er adjustment for vascular risk factors [6] ; however, there was no consensus about the relationship between WBC count and the prognosis a er onset of cerebral infarction. Some studies had found that increased WBC count in the rst day of acute ischemic stroke is a prognostic factor of disease progression [7] , and the WBC count was an important predictive factor of in-hospital death [8] . ere were also some studies [9] [10] [11] that did not nd an association between the admission WBC count and clinical outcome. In China, there has been no large-sample data on the relationship between WBC count at admission and short term clinical outcomes among patients with acute cerebral infarction. e purpose of the present study is to examine the association between WBC count at admission and short term clinical outcomes, including death and dependency, among acute cerebral infarction patients in China.
Participants and Methods

Study participants
Acute cerebral infarction patients were recruited from the afliated hospital of Hebei United University, China. Written informed consent was obtained for all study participants or their family members. All the patients with a clinical diagnosis of acute cerebral infarction admitted to the hospital from January 1, 2003 to December 31, 2009 were potentially eligible for the study; however, only those whose diagnosis was con rmed by a computed tomography (CT) scan or magnetic resonance imaging (MRI) and whose admission times from onset were less than 72 hours were included. A team of investigators, including neurologists, reviewed the eligibility of study participants. Among the 3256 acute cerebral infarction patients admitted to the hospital during the study period, all of whom had a CT or MRI con rmed cerebral infarction, only 2808 patients were included in our analysis. A total of 448 patients were excluded from our analysis according to the following exclusion criteria: recent acute infection including prior to admission, history of active leukemia/lymphoma, use of thrombolysis a er admission, use of medications that could a ect blood cell counts such as prednisone or chemotherapeutic agents. is study was approved by Soochow University and Hebei United University Ethics Committees.
Data collection
Baseline data were collected within the rst 24 hours of admission during an interview with patients or their family members (if patients were not able to communicate). Data on demographic characteristics, lifestyle risk factors, medical history, complications, NIH stroke score (NIHSS), clinical laboratory tests and imaging data (CT and MRI) were obtained by trained sta s for all participants. Cigarette smokers were dened as having smoked at least 1 cigarette per day for 1 year or more. Details on the amount and type of alcohol consumption during the past year were collected. Alcohol consumption was de ned as consuming one or more alcoholic drinks per week during the past year. Complications included myocardial infarction, heart failure, renal failure and pneumonia at admission e WBC count was measured using a fully automated hematology analyzer (ABX PENTRA 60, France). Fasting plasma glucose levels were measured using a modi ed hexokinase enzymatic method. Total cholesterol, high-density lipoprotein(HDL)-cholesterol and triglycerides were analyzed enzymatically using a Beckman Synchron CX5 Delta Clinical System (Beckman Coulter, Fullerton, USA) using commercial reagents. Low-density lipoprotein (LDL)-cholesterol levels were calculated by the use of the Friedewald equation for the participants.
e study outcomes included in-hospital death and dependency at discharge. If a patient died in the hospital, a study sta member recorded the death on the event form and obtained the death certi cate. If a patient survived the acute stroke, the neurologists conducted a comprehensive clinical evaluation at discharge. Dependency was de ned as moderate or severe disability at discharge using a modi ed Rankin Scale (mRS)>2 [12] .
Statistical analysis
e mean and standard deviation of continuous variables and proportion of categorical variables at admission were calculated for the death, dependency and non-dependency (mRS≤2) participants. e participants were grouped by the WBC count level (<10.0×10 9 /L, 10.0-10.9×10 9 /L, 11.0-11.9×10 9 /L and ≥12.0×10 9 /L), multivariate logistic regression analysis was Peng et al. WBC and stroke outcome etes, corona ary heart diseases and stroke, smoking and drinkused to examine the association between WBC count and study outcomes (death or dependency), adjusted for age, time from stroke onset to admission, hypertension, history of diabetes, coronary heart diseases and stroke, smoking and drinking, dyslipidemia, hyperglycemia, NIHSS and complications at admission. Odds ratio (OR) and 95% con dence interval (95% CI) were calculated for each group, using the group with the lowest WBC count as a reference. Statistical analyses were conducted using SPSS statistical so ware (version 13.0).
Results
A total of 117 death cases, 713 dependency cases and 1978 non-dependency cases were included in the present analysis.
e median time from onset of symptom to admission was 24 hours; the median duration of hospitalization was 15 days. e demographic and clinical characteristics of acute cerebral infarction patients at admission by the study outcomes are presented in Table 1 . Deaths were more likely to occur in older patients, and those with hypertension, histories of diabetes, stroke, coronary heart diseases, smoking and drinking, dyslipidemia, hyperglycemia, complications at admission, and higher NIHSS and WBC count at admission compared with survivors. e dependency cases were more likely to be older, have histories of diabetes, coronary heart diseases and stroke, smoking, drinking, hyperglycemia, have complications at admission, and have higher NIHSS and WBC count at admission compared with those without dependency. ere was no signi cant di erence in gender among the death, dependency and nondependent patients.
ere was positive and signi cant association between WBC count at admission and study outcome ( Table 2) . Compared with those with WBC<10.0×10 9 /L, unadjusted ORs of dependency were all positive and signi cant for the patients with WBC count of 10.0-10.9×10 9 /L, 11.0-11.9×10 9 /L, ≥12.0×10 9 /L. e ORs of dependency associated with WBC count of 11.0-11.9×10 9 /L and ≥12.0×10 9 /L remained signicant a er adjustment for multivariate, the risk of dependency in the patients with WBC≥12.0×10 9 /L was 7.01 times those with WBC<10.0×10 9 /L. unadjusted ORs of death were all positive and signi cant for the patients with WBC count of 10.0-10.9×10 9 /L, 11.0-11.9×10 9 /L and ≥12.0×10 9 /L. e ORs of death associated with WBC count of 11.0-11.9×10 9 /L and ≥12.0×10 9 /L remained signi cant a er adjustment for multivariate, the risk of death in the patients with WBC count of 11.0-11.9×10 9 /L and ≥12.0×10 9 /L was 4.79 and 5.59, respectively, compared with those with WBC<10.0×10 9 /L.
Discussion
We conducted a large-sample study on the relationship between WBC count at admission and short term clinical outcomes among acute cerebral infarction patients. Increased WBC count at admission was found to be independently associated with in-hospital death and dependency at discharge among patients with acute cerebral infarction. WBC count was higher in the death cases than in the dependency cases and higher in the death and dependency cases than in nondependent cases. Furthermore, admission WBC counts of 11. 0-11.9×10 9 /L, ≥12. 0×10 9 /L were associated with 6.21 and 7.01-fold increase in the risk of dependency, and 4.79 and 5.59-fold increase in the risk of death among acute cerebral infarction patients compared with WBC counts <10. 0×10 9 / L. Some factors, including age, time from stroke onset to admission, histories of hypertension, diabetes, coronary heart diseases and stroke, NIHSS and complications at admission, were adjusted by using a multiple logistic model. e observational ndings suggest that WBC count at admission maybe predict the occurrence of poor outcome in short term among acute cerebral infarction patients.
Some studies have showed that in ammatory biomarkers are associated with the risk of future ischemic events in the general population. In a meta-analysis, Danesh et al. reported that relative risk of cardiovascular disease associated with upper tertiles of leukocyte count, CRP and brinogen was 1.4, 1.7 and 1.8, respectively, compared with lowest tertiles [13] . Elkind's study [6] showed that increased baseline leukocyte counts might independently predict occurrence of rst cerebral infarction, and Armin et al. [14] reported that elevated baseline leukocyte counts were independently associated with ischemic events in the high-risk populations with ischemic stroke, myocardial infarction or peripheral arterial disease. Brown [15] reported that elevated WBC may predict mortality from cerebrovascular disease a er adjustment for the e ects of smoking and other cardiovascular disease risk factors. ere are two studies [16, 17] of patients in whom bacterial infections lead to increased WBC counts, which suggest that acute bacterial infections may be associated with ischemic events. ere are, however, con icting reports about the association between WBC count and the prognosis a er onset of cerebral infarction [8] [9] [10] [11] . In 763 unselected patients with stroke, admitted within 24 hours from onset, Kammersgaard et al. [9] prospectively studied the relationship between leukocyte count and clinical outcome. eir ndings showed that leukocytosis at admission was related to initial stroke severity but not to outcome; leukocyte count at admission seems merely to re ect initial stroke severity and is most likely a stress response with Peng et al. WBC and stroke outcome no independent in uence on outcome. Kazmierski's study [8] showed that an increased WBC count within the rst 12 h of onset of an ischemic stroke was a strong prognostic factor for in-hospital mortality in 400 consecutive acute stroke patients. In the Northern Manhattan Stroke Study [18] , 655 patients with rst ischemic stroke were prospectively followed for 5 years for the occurrence of recurrent stroke, myocardial infarction or death. eir ndings indicated that elevated leukocyte count at the time of ischemic stroke predicts future recurrent stroke, myocardial infarction or death. Turaj's study [19] showed that the WBC count was an independent predictor of one-year case-fatality among 900 patients with ischemic stroke admitted to the hospital within 24 h a er onset of symptoms. Compared with previous studies, our study is a larger survey sample, which includes 2808 ischemic cerebral infarction patients unselected from 2003 to 2009 in a hospital. Although data about infarct size, associated with severity of stroke, was not collected in this study, some important covariates were adjusted for, including NIHSS and complications at admission, which might re ect severity of stroke and were related to the prognosis. e time length from stroke onset to admission may complicate the analysis, however, the time length from stroke onset to admission was adjusted for. Our ndings, therefore, support the concept that an elevated WBC count is an independent risk factor for in-hospital death, or short term poor outcomes, in ischemic cerebral infarction patients.
e mechanisms linking WBC count to clinical outcome are insu ciently understood. Buck et al. [20] reported that, in acute ischemic stroke, early elevation of total leukocyte count and neutrophil count is associated with a larger volume of early ischemic tissue. A study by Audebert et al. [21] showed that an increase in in ammatory parameters (C-reactive protein and WBC count) correlated signi cantly with lesion volume and stroke severity. Increased WBC count may make a major contribution to the rheologic properties of blood, alter adhesive properties under stress, including the stress of ischemia, and participate in endothelial injury, both acutely and chronically, by adhering to endothelium and damaging it with toxic oxygen compounds and proteolytic enzymes [22] .
Our study has some limitations. Firstly, the study is an observational study and not a multicenter clinical study. Secondly, the participants included some patients whose time from onset to admission exceeded 24 hours, and whose WBC count at admission maybe not accurately re ect the levels of WBC at stroke onset. irdly, the data of long term outcomes a er the discharge was not collected; therefore, these ndings are limited to explanations of short term outcomes.
In summary, our study found that increased WBC count at admission was signi cantly and positively associated with inhospital death and with dependency at discharge. Our ndings suggest that increased WBC is an independent risk factor for short term poor outcomes among patients with acute cerebral infarction.
